Literature DB >> 19744599

Nephrogenic systemic fibrosis: histology and gadolinium detection.

Charu Thakral1, Jerrold L Abraham.   

Abstract

The association between gadolinium (Gd)-containing MR imaging contrast agents and the development of nephrogenic systemic fibrosis (NSF) is well recognized. The authors review the histopathologic features, methodology, and results of analysis of tissues for Gd in NSF. Scanning electron microscopy/energy dispersive x ray spectroscopy (SEM/EDS) provides sensitive detection of individual Gd-containing deposits in situ. Secondary ion mass spectroscopy has far greater sensitivity for detection of Gd than SEM/EDS and allows correlation at the cellular level. Inductively coupled plasma mass spectrometry is the recognized method for full quantitative analysis of Gd in tissues but requires destruction of the tissue and does not allow spatial correlation. In practice, the different analytic techniques provide complementary data and can be selected based on the information required.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19744599     DOI: 10.1016/j.rcl.2009.06.005

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  6 in total

1.  Signal intensity increases in dentate nucleus/globus pallidus/pulvinar on unenhanced T1WI MR images after multiple examinations with gadodiamide.

Authors:  Takao Koiso; Masaaki Yamamoto; Shinya Watanabe; Bierta E Barfod
Journal:  Neuroradiol J       Date:  2019-03-29

2.  Hyperintense Dentate Nuclei on T1-Weighted MRI: Relation to Repeat Gadolinium Administration.

Authors:  M E Adin; L Kleinberg; D Vaidya; E Zan; S Mirbagheri; D M Yousem
Journal:  AJNR Am J Neuroradiol       Date:  2015-08-20       Impact factor: 3.825

Review 3.  Evaluating the Patient with Reported Gadolinium-Associated Illness.

Authors:  Tatyana Lyapustina; Charlotte Goldfine; Sean Rhyee; Kavita M Babu; Matthew K Griswold
Journal:  J Med Toxicol       Date:  2018-11-29

Review 4.  Gadolinium and nephrogenic systemic fibrosis: an update.

Authors:  Alex Weller; Joy L Barber; Oystein E Olsen
Journal:  Pediatr Nephrol       Date:  2013-10-22       Impact factor: 3.714

Review 5.  Cutaneous manifestations of ESRD.

Authors:  Timur A Galperin; Antonia J Cronin; Kieron S Leslie
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-10       Impact factor: 8.237

6.  Nephrogenic systemic fibrosis: current concepts.

Authors:  Prasanta Basak; Stephen Jesmajian
Journal:  Indian J Dermatol       Date:  2011-01       Impact factor: 1.494

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.